These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2620532)

  • 1. Cervagem/Dilapan for preoperative cervical dilatation prior to vacuum aspiration for termination of first trimester pregnancy. A prospective randomized study.
    Jürgensen U; Christensen NJ
    Contraception; 1989 Dec; 40(6):741-9. PubMed ID: 2620532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical dilatation with 16,16-dimethyl-trans-delta 2-PGE1 methyl ester (Cervagem) prior to vacuum aspiration. A double-blind, placebo-controlled randomized study.
    Christensen NJ; Bygdeman M
    Contraception; 1984 May; 29(5):457-64. PubMed ID: 6378517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Gemeprost vaginal suppository for cervical priming prior to termination of first trimester pregnancy.
    Kajanoja P; Mandelin M; Mäkilä UM; Ylikorkala O; Felding C; Somell C; Olund A; Pedersen H
    Contraception; 1984 Mar; 29(3):251-60. PubMed ID: 6539662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled study of 16,16-dimethyl-trans-delta 2 prostaglandin E1 methyl ester vaginal pessaries prior to suction termination of first trimester pregnancies.
    Fisher PR; Taylor JH
    Br J Obstet Gynaecol; 1984 Nov; 91(11):1141-4. PubMed ID: 6388625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of gemeprost (Cervagem) pessaries and Lamicel tents for cervical preparation for abortion by dilatation and suction.
    Helm CW; Davies N; Beard RJ
    Br J Obstet Gynaecol; 1988 Sep; 95(9):911-5. PubMed ID: 3056505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-operative cervical preparation before first trimester vacuum aspiration: a randomized controlled comparison between gemeprost and mifepristone (RU 486).
    Henshaw RC; Templeton AA
    Br J Obstet Gynaecol; 1991 Oct; 98(10):1025-30. PubMed ID: 1751434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is misoprostol the drug of choice for induced cervical ripening in early pregnancy termination?
    Platz-Christensen JJ; Nielsen S; Hamberger L
    Acta Obstet Gynecol Scand; 1995 Nov; 74(10):809-12. PubMed ID: 8533565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulprostone (Nalador) versus gemeprost (Cervagem) for cervical priming in the termination of pregnancy during the first trimester.
    Heinzl S; Hendry M
    Contraception; 1987 Mar; 35(3):271-82. PubMed ID: 3608482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative dilatation of the cervix by single vaginal administration of 15-methyl-PGF2alpha-methyl ester.
    Ganguli AC; Gréen K; Bygdeman M
    Prostaglandins; 1977 Oct; 14(4):779-84. PubMed ID: 339282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of vaginal misoprostol and gemeprost as pre-treatment in first trimester pregnancy interruption.
    Henry AM; Haukkamaa M
    Br J Obstet Gynaecol; 1999 Jun; 106(6):540-3. PubMed ID: 10426610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predilatation of the cervix in first trimester termination of pregnancy. A comparative study of the prostaglandin analogue, 16,16 dimethyl-trans-delta 2-PGE1, methyl ethyl ester (Cervagem) and mechanical dilatation.
    Kuah KB
    Aust N Z J Obstet Gynaecol; 1993 May; 33(2):162. PubMed ID: 8216116
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral misoprostol versus placebo for cervical dilatation before vacuum aspiration in first trimester pregnancy.
    Ngai SW; Tang OS; Lao T; Ho PC; Ma HK
    Hum Reprod; 1995 May; 10(5):1220-2. PubMed ID: 7657769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal misoprostol for pre-abortion cervical priming: is there an optimal evacuation time interval?
    Singh K; Fong YF; Prasad RN; Dong F
    Br J Obstet Gynaecol; 1999 Mar; 106(3):266-9. PubMed ID: 10426647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gemeprost and mifepristone on the mechanical properties of the cervix prior to first trimester termination of pregnancy.
    Carbonne B; Brennand JE; Maria B; Cabrol D; Calder AA
    Br J Obstet Gynaecol; 1995 Jul; 102(7):553-8. PubMed ID: 7647058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of gemeprost alone, dilapan or mifepristone in combination with gemeprost for the termination of second trimester pregnancy.
    Thong KJ; Baird DT
    Contraception; 1992 Jul; 46(1):11-7. PubMed ID: 1424619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does an acidic medium enhance the efficacy of vaginal misoprostol for pre-abortion cervical priming?
    Singh K; Fong YF; Prasad RN; Dong F
    Hum Reprod; 1999 Jun; 14(6):1635-7. PubMed ID: 10357990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study using two dose regimens (200 microg or 400 microg) of vaginal misoprostol for pre-operative cervical dilatation in first trimester nulliparae.
    Fong YF; Singh K; Prasad RN
    Br J Obstet Gynaecol; 1998 Apr; 105(4):413-7. PubMed ID: 9609268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of a new vaginal suppository: prostaglandin E1 analog Gemeprost for cervix maturation prior to abortion in the 1st trimester].
    Rabe T; Helk J; Kiesel L; Zwick J; Runnebaum B
    Geburtshilfe Frauenheilkd; 1985 Jun; 45(6):393-401. PubMed ID: 3894147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of prostaglandin E1 analogue pessaries in patients having first trimester induced abortions.
    Nakano R; Hata H; Sasaki K; Yamoto M
    Br J Obstet Gynaecol; 1980 Apr; 87(4):287-91. PubMed ID: 7426498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of progesterone antagonist RU486 (mifepristone) for pre-operative cervical dilatation during first trimester abortion.
    Durlot F; Dubois C; Brunerie J; Frydman R
    Hum Reprod; 1988 Jul; 3(5):583-4. PubMed ID: 3170699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.